RUBICONPharmaceuticals
Rubicon Research — Financial Ratios & Key Metrics
₹640.20
+0.00%
P/E Ratio68.60xIndustry: 31.77x
ROE29.02%Return on equity
ROCE26.16%Return on capital
Debt/Equity0.88Low debt
💎
Valuation & Profitability
P/E Ratio
68.60xIndustry Average P/E
31.77xDividend Yield
0.00%Market Cap
₹10.55K (Cr)Sales Growth 5Y
37.32%Profit Growth 5Y
22.95%EPS Growth 5Y
-37.89%OPM 5Y Avg
15.50%📉
Price Returns
1 Month
+3.57%
3 Months
+N/A
6 Months
+N/A
1 Year
+N/A
More on Rubicon Research
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.